Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rilonacept in DIRA
NCT01801449Phase 2Completed
- Sponsor
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Start
- Feb 2013
- Primary completion
- Apr 2016
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of rilonacept, sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases. Started Feb 2013; status: completed.
02
Drugs
rilonacept
Beyond the preview
Go deeper on NCT01801449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01801449.